← Back to Clinical Trials
Recruiting NCT06496945

NCT06496945 Assessing the Impact of DAy Programs on Individuals Living with Dementia and Their Family/friend Caregivers

◆ AI Clinical Summary
Plain-language summary for patients
Clinical Trial Summary
NCT ID NCT06496945
Status Recruiting
Phase
Sponsor York University
Condition Adult Day Programs
Study Type OBSERVATIONAL
Enrollment 3,000 participants
Start Date 2024-11-01
Primary Completion 2026-04-30

Eligibility & Interventions

Sex All sexes
Min Age 65 Years
Max Age N/A
Study Type OBSERVATIONAL
Interventions
Adult day program useOther community care (non-attendees)

Eligibility Fast-Check

Enter your details for a quick preliminary check. This does not replace medical advice.

What to Expect as a Participant

This is an observational study. You will not receive an experimental treatment; researchers will collect data based on your existing condition or standard treatment.

This trial targets 3,000 participants in total. It began in 2024-11-01 with a primary completion date of 2026-04-30.

⚠ This information is for research awareness only. Always consult your physician before joining any clinical trial. Participation is voluntary and you may withdraw at any time.

Brief Summary

This study seeks to understand the effects of adult day programs on older adults, especially those with dementia, and their caregivers. A prospective cohort study will be conducted in the Canadian provinces of Alberta, British Columbia, Manitoba, and Ontario. Participants will be (1) older adults with dementia who attend a day program, and their caregivers, and (2) older adults with dementia in the community who do not attend a day program, and their caregivers. The objectives are to (1) evaluate the effects of day programs on attendee and caregiver outcomes, and (2) compare day program use patterns, attendee and caregiver social identities, day program characteristics, and day program outcomes between the 4 provinces, and (3) to explore what attendee and caregiver social identities and day program characteristics are associated with study outcomes, and with day program attendance/non-attendance.

Eligibility Criteria

Inclusion Criteria: * Older adults (65+ years) with a diagnosis of dementia, who live in the community, and either attend an adult day program (cohort 1), or receive continuing care in the community with an initial RAI-HC assessment completed (cohort 2) * Primary caregiver (i.e., most involved with and informed about the care) of an eligible older adult Exclusion Criteria: * Older adults with or without dementia who do not receive any community-based continuing care service * Day program attendees or community care recipients who do not have a diagnosis of dementia or who are younger than 65 years * Secondary caregivers

Contact & Investigator

Central Contact

Matthias Hoben, Dr rer medic

✉ mhoben@yorku.ca

📞 +1 437-335-1338

Principal Investigator

Matthias Hoben, Dr rer medic

PRINCIPAL INVESTIGATOR

York University

Frequently Asked Questions

Who can join the NCT06496945 clinical trial?

This trial is open to participants of all sexes, aged 65 Years or older, studying Adult Day Programs. Full inclusion and exclusion criteria are listed in the Eligibility Criteria section. Always confirm your eligibility with the research team before applying.

Is NCT06496945 currently recruiting?

Yes, NCT06496945 is actively recruiting participants. Contact the research team at mhoben@yorku.ca for enrollment information.

Where is the NCT06496945 trial being conducted?

This trial is being conducted at Edmonton & Calgary, Canada, Multiple, Canada, Winnipeg, Canada, Multiple, Canada.

Who is sponsoring the NCT06496945 clinical trial?

NCT06496945 is sponsored by York University. The principal investigator is Matthias Hoben, Dr rer medic at York University. The trial plans to enroll 3,000 participants.

Related Trials

ClinicalMetric — Independent clinical trial intelligence platform. Not affiliated with NIH, ClinicalTrials.gov, the U.S. FDA, or any pharmaceutical company, hospital, or clinical research organization. Trial data is sourced from ClinicalTrials.gov for informational purposes only and does not constitute medical advice. Do not make any treatment, enrollment, or health decisions based solely on information found here — always consult a qualified healthcare professional. Full Disclaimer  ·  Last Reviewed: September 2026  ·  Data Methodology